Tag: THUNDER study
THUNDER study demonstrates safety and effectiveness of modulated aspiration in stroke...
Penumbra today announced the results of THUNDER, which is an investigational device exemption (IDE) study intended to evaluate the safety and effectiveness of Thunderbolt—the company's...
Computer-assisted vacuum thrombectomy arrives in stroke care with Thunderbolt US FDA...
Penumbra has announced it has received US Food and Drug Administration (FDA) clearance for Thunderbolt, expanding its computer-assisted vacuum thrombectomy (CAVT) technology into the world of...
Penumbra announces completion of enrolment in THUNDER IDE study
Penumbra has announced the completion of enrolment in its THUNDER investigational device exemption (IDE) clinical study for patients with acute ischaemic stroke.
THUNDER is evaluating...
